The U-M Health Rogel Cancer Center's Gynecologic Oncology Program is a team of fellowship-trained gynecologic oncologists providing comprehensive, personalized cancer care. We follow National Comprehensive Cancer Network (NCCN) guidelines to develop treatment plans tailored to each patient’s diagnosis, stage, and goals. As an NCCN founding member institution, we offer access to the latest evidence-based treatments and the most clinical trials available for each disease.

To get the appointment process started, call 734-647-8902. If you are a referring physician, please contact our M-LINE at 800-962-3555. 

If you have questions, please contact our Cancer AnswerLine at 800-865-1125.

Most GTD is benign (not cancer) and does not invade into body tissues or spread to other parts of the body, however, some are malignant (cancerous). Gestational trophoblastic neoplasia (GTN) is a type of gestational trophoblastic disease (GTD) that is almost always malignant. GTDs are rare tumors. The main types of GTD include:

• Hydatidiform mole (molar pregnancy) – complete or partial
• Gestational trophoblastic neoplasia
  • Invasive mole
  • Choriocarcinoma
  • Placental-site trophoblastic tumor
  • Epithelioid trophoblastic tumor

All types of GTD can be treated and treatment often results in a complete cure. The treatment for GTD depends on the specific type of tumor, stage, and other factors.